U.S. regulators approve second gene therapy for blood cancer

U.S. regulators approve second gene therapy for blood cancer

By Associated Press  |  October 19, 2017

Kite Pharma's newly approved blood cancer treatment, Yescarta, uses gene therapy techniques not to fix disease-causing genes but to turbocharge T cells, immune system soldiers that cancer can often evade.

FDA requires opioid makers to develop doctor training

By Associated Press  |  September 29, 2017

The agency notified 74 manufacturers of so-called immediate-release opioids that their drugs will now be subject to the tougher requirements, although doctors would not be compelled to take part in the training.

Groups seek ban on high-dose opioids citing overdose danger

By Associated Press  |  August 31, 2017

Safety advocates and state health officials are formally calling on the Food and Drug Administration to ban high-dose opioid painkillers to prevent accidental overdose deaths among patients and people who abuse drugs.

U.S. clears first 'living drug' for childhood leukemia

By Associated Press  |  August 30, 2017

Opening a new era in cancer care, the Food and Drug Administration approved the first treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia.


Subscribe and SAVE 50%

View our best offer
Subscribe to Print